Moderna pulls licensing submission for combo flu-COVID vaccine

cidrap.umn.edu/covid-19/moderna-pulls-licensing-submission-combo-flu-covid-vaccine

Today vaccine maker Moderna announced it voluntarily pulled its licensing submission for the combination seasonal influenza–COVID-19 mRNA vaccine candidate, mRNA-1083, so that it can submit efficacy data.
The news comes a day after the US Food and Drug Administration announced that…

This story appeared on cidrap.umn.edu, 2025-05-22 02:05:23.177000.
The Entire Business World on a Single Page. Free to Use →